We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Authorized Generics May Draw More FTC Scrutiny, Expert Says
Authorized Generics May Draw More FTC Scrutiny, Expert Says
October 7, 2005
Although an increasing number of generic drugmakers appear willing to participate in the authorized generics market, the controversial practice may soon face increased scrutiny from the FTC, according to an industry expert.